Stock Track | Alvotech Plunges 5.04% After Hours on Q1 Earnings Miss and Revenue Decline

Stock Track
05/07

Alvotech's stock fell 5.04% in post-market trading on Wednesday, following the release of its first-quarter financial results.

The biotechnology company reported revenue of $105.9 million for Q1 2026, a 20.3% decrease from the same period last year and significantly below analyst estimates of $140.85 million. Earnings per share were breakeven, missing expectations of 2 cents per share.

CEO Lisa Graver stated that both revenues and EBITDA were impacted by a production slowdown related to facility improvements, with a recovery expected as normal operations resume. The company maintained its full-year revenue guidance of $650-$700 million and adjusted EBITDA guidance of $180-$220 million.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10